Protagonist Therapeutics Stock Price History
| PTGX Stock | USD 47.47 0.11 0.23% |
Below is the normalized historical share price chart for Protagonist Therapeutics extending back to August 11, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Protagonist Therapeutics stands at 47.47, as last reported on the 31st of May, with the highest price reaching 47.74 and the lowest price hitting 46.16 during the day.
If you're considering investing in Protagonist Stock, it is important to understand the factors that can impact its price. Protagonist Therapeutics appears to be very steady, given 3 months investment horizon. Protagonist Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0777, which implies the firm had a 0.0777 % return per unit of risk over the last 3 months. By analyzing Protagonist Therapeutics' technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please evaluate Protagonist Therapeutics' Semi Deviation of 2.17, coefficient of variation of 1096.52, and Risk Adjusted Performance of 0.1629 to confirm if our risk estimates are consistent with your expectations.
At this time, Protagonist Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 782 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 33.6 M in 2025. . At this time, Protagonist Therapeutics' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 3.70 in 2025, whereas Price To Sales Ratio is likely to drop 5.20 in 2025. Protagonist Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of August 2016 | 200 Day MA 43.3643 | 50 Day MA 45.9064 | Beta 2.641 |
Protagonist | Build AI portfolio with Protagonist Stock |
Sharpe Ratio = 0.0777
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PTGX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.39 actual daily | 57 57% of assets are less volatile |
Expected Return
| 0.5 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Protagonist Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protagonist Therapeutics by adding it to a well-diversified portfolio.
Price Book 4.27 | Enterprise Value Ebitda 78.9882 | Price Sales 14.1592 | Shares Float 46.2 M | Wall Street Target Price 68.7 |
Protagonist Therapeutics Stock Price History Chart
There are several ways to analyze Protagonist Stock price data. The simplest method is using a basic Protagonist candlestick price chart, which shows Protagonist Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 11, 2025 | 59.76 |
| Lowest Price | March 7, 2025 | 38.35 |
Protagonist Therapeutics May 31, 2025 Stock Price Synopsis
Various analyses of Protagonist Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Protagonist Stock. It can be used to describe the percentage change in the price of Protagonist Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Protagonist Stock.| Protagonist Therapeutics Price Rate Of Daily Change | 1.00 | |
| Protagonist Therapeutics Price Action Indicator | 0.46 | |
| Protagonist Therapeutics Price Daily Balance Of Power | (0.07) | |
| Protagonist Therapeutics Accumulation Distribution | 26,059 |
Protagonist Therapeutics May 31, 2025 Stock Price Analysis
Protagonist Stock Price History Data
The price series of Protagonist Therapeutics for the period between Sun, Mar 2, 2025 and Sat, May 31, 2025 has a statistical range of 23.61 with a coefficient of variation of 10.96. The price distribution for the period has arithmetic mean of 46.11. The median price for the last 90 days is 45.75.| Open | High | Low | Close | Volume | ||
05/30/2025 | 47.37 | 47.74 | 46.16 | 47.47 | 787,365 | |
05/29/2025 | 45.89 | 47.65 | 45.43 | 47.58 | 688,504 | |
05/28/2025 | 46.48 | 46.85 | 45.67 | 45.75 | 664,976 | |
| 05/27/2025 | 46.42 | 46.51 | 45.28 | 46.43 | 850,554 | |
05/23/2025 | 45.69 | 45.99 | 45.14 | 45.66 | 486,198 | |
05/22/2025 | 45.63 | 46.03 | 45.18 | 45.91 | 901,585 | |
| 05/21/2025 | 46.02 | 46.80 | 45.05 | 45.82 | 832,191 | |
05/20/2025 | 45.60 | 46.63 | 44.72 | 46.61 | 535,195 | |
05/19/2025 | 44.45 | 45.58 | 44.04 | 45.57 | 551,847 | |
05/16/2025 | 44.35 | 45.20 | 44.11 | 44.49 | 647,034 | |
05/15/2025 | 44.12 | 44.76 | 43.47 | 44.41 | 625,803 | |
05/14/2025 | 44.44 | 45.26 | 43.20 | 43.77 | 840,130 | |
05/13/2025 | 45.23 | 45.23 | 43.27 | 44.27 | 910,114 | |
| 05/12/2025 | 43.77 | 45.83 | 43.75 | 45.27 | 1,000,897 | |
| 05/09/2025 | 44.15 | 45.43 | 42.85 | 42.97 | 671,228 | |
05/08/2025 | 42.60 | 44.37 | 41.60 | 43.92 | 1,100,691 | |
05/07/2025 | 41.77 | 43.20 | 41.29 | 43.09 | 1,360,357 | |
| 05/06/2025 | 43.86 | 44.23 | 41.74 | 42.01 | 807,789 | |
| 05/05/2025 | 45.39 | 45.53 | 44.20 | 44.28 | 876,702 | |
05/02/2025 | 45.05 | 46.12 | 44.82 | 45.51 | 644,081 | |
05/01/2025 | 45.23 | 45.63 | 43.49 | 44.99 | 739,458 | |
04/30/2025 | 45.25 | 46.02 | 44.22 | 45.82 | 860,806 | |
04/29/2025 | 44.16 | 46.00 | 43.69 | 45.62 | 1,254,834 | |
| 04/28/2025 | 44.49 | 45.50 | 44.08 | 44.39 | 592,375 | |
04/25/2025 | 44.36 | 44.84 | 43.62 | 44.49 | 634,255 | |
04/24/2025 | 45.96 | 46.06 | 44.27 | 44.85 | 859,223 | |
| 04/23/2025 | 47.13 | 47.35 | 45.73 | 46.16 | 1,416,211 | |
| 04/22/2025 | 46.00 | 46.41 | 45.42 | 45.85 | 775,163 | |
04/21/2025 | 46.05 | 46.97 | 45.07 | 45.80 | 1,189,681 | |
| 04/17/2025 | 45.83 | 46.87 | 45.80 | 46.28 | 517,389 | |
04/16/2025 | 46.75 | 47.14 | 45.00 | 45.80 | 1,329,850 | |
04/15/2025 | 45.20 | 48.32 | 44.97 | 46.95 | 2,147,622 | |
04/14/2025 | 43.22 | 45.51 | 42.53 | 45.03 | 1,162,809 | |
04/11/2025 | 41.10 | 42.63 | 41.10 | 42.62 | 1,157,827 | |
04/10/2025 | 41.44 | 43.00 | 39.90 | 40.89 | 1,638,942 | |
04/09/2025 | 41.06 | 43.91 | 39.60 | 42.57 | 1,868,876 | |
04/08/2025 | 44.10 | 45.88 | 40.88 | 41.67 | 2,073,462 | |
04/07/2025 | 43.42 | 45.32 | 42.44 | 43.21 | 1,590,204 | |
04/04/2025 | 45.09 | 46.45 | 43.93 | 44.44 | 1,749,567 | |
04/03/2025 | 47.06 | 47.25 | 45.79 | 46.50 | 1,482,011 | |
04/02/2025 | 46.68 | 48.93 | 46.39 | 48.20 | 1,223,112 | |
04/01/2025 | 47.99 | 48.68 | 46.54 | 46.88 | 1,095,298 | |
03/31/2025 | 47.92 | 48.80 | 47.09 | 48.36 | 1,212,096 | |
03/28/2025 | 49.47 | 50.48 | 48.80 | 48.88 | 664,503 | |
03/27/2025 | 49.33 | 50.52 | 49.33 | 49.44 | 715,396 | |
03/26/2025 | 51.09 | 51.40 | 49.40 | 49.56 | 881,894 | |
| 03/25/2025 | 52.60 | 53.58 | 50.72 | 51.05 | 790,374 | |
03/24/2025 | 53.30 | 53.70 | 51.61 | 52.53 | 1,521,943 | |
03/21/2025 | 53.23 | 53.23 | 51.06 | 52.65 | 3,695,676 | |
03/20/2025 | 53.67 | 54.11 | 52.47 | 53.05 | 890,943 | |
03/19/2025 | 54.45 | 54.54 | 52.43 | 54.35 | 1,048,614 | |
03/18/2025 | 52.58 | 54.55 | 51.84 | 54.52 | 784,643 | |
| 03/17/2025 | 54.16 | 54.25 | 52.26 | 53.01 | 1,284,621 | |
03/14/2025 | 55.00 | 55.39 | 53.53 | 54.78 | 1,271,555 | |
| 03/13/2025 | 57.90 | 58.70 | 54.79 | 54.90 | 1,399,161 | |
03/12/2025 | 59.58 | 60.60 | 56.66 | 57.65 | 2,252,061 | |
03/11/2025 | 55.90 | 60.14 | 54.12 | 59.76 | 2,618,082 | |
03/10/2025 | 50.08 | 57.97 | 48.50 | 55.95 | 5,225,826 | |
03/07/2025 | 38.89 | 39.90 | 37.94 | 38.35 | 1,598,931 | |
03/06/2025 | 37.92 | 39.40 | 37.92 | 39.05 | 1,033,291 | |
| 03/05/2025 | 38.78 | 39.64 | 37.67 | 38.45 | 1,509,646 |
About Protagonist Therapeutics Stock history
Protagonist Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Protagonist is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Protagonist Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Protagonist Therapeutics stock prices may prove useful in developing a viable investing in Protagonist Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 65.1 M | 33.6 M | |
| Net Loss | -114.7 M | -108.9 M |
Protagonist Therapeutics Quarterly Net Working Capital |
|
Protagonist Therapeutics Stock Technical Analysis
Protagonist Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Protagonist Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Protagonist Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Protagonist Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Protagonist to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1629 | |||
| Jensen Alpha | 0.5647 | |||
| Total Risk Alpha | 0.6957 | |||
| Sortino Ratio | 0.2378 | |||
| Treynor Ratio | 4.84 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.